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Keratinocyte intercellular adhesion molecule-l 
(ICAM-l) is important in mediating retention of T 
cells within the epidermal compartment. To deter-
II1ine if antisense oligonucleotides designed to hybri-
dize to various ICAM-l mRNA regions could selec-
tively influence cultured keratinocyte ICAM-l 
expression following gamma interferon (IFN-y), cells 
were exposed to several antisense compounds, in the 
absence and presence of cationic lipid (lipofectin). 
Keratinocytes rapidly internalized sense and antisense 
compounds (within 30 - 60 min), even in the absence of 
Hpofectin with approximately 30% of the cell possess-
ing positive nuclei. Such nuclear accumulation was not 
observed in the absence oflipofectin in cultured fibro-
blasts, smooth muscle cells, or endothelial cells, even 
though total cellular uptake within the cytoplasm was 
significantly increased in all these cell types. Using 
So-called antisense oligonucleotides bind to the mRNA or pre-mRNA within cells inhibiting synthesis of the target protein by multiple mechanisms, such as RNase H-me-diated degradation of the RNA, inhibition of RNA pro-cessing, or translational arrest [1,2]. Although numerous 
experiments have utilized natural phosphodiester deoxynucleotides 
to inhibit gene expression, they are limited in their utility due to the 
rapid degradation by serum and cellular nucleases [3 - 5]. Antisense 
oligonucleotides can be modified to produce phosphorothioate ana-
logs that are less sensitive towards nuclease degradation, and stable 
antisense oligonucleotide analogs directed against intercellular ad-
hesion molecule-1 (ICAM-1) mRNA have been reported using cy-
to kine-activated endothelial cells and a bronchial carcinoma cell 
line [6]. Using human umbilical vein endothelial cells, the uptake 
and biologic activity of these antisense oligonucleotides was in-
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flow cytometry, IFN-y-inducible ICAM-l expression 
was reduced 50% by antisense compounds with lipo-
fectin, and by 30% without lipofectin. This inhibition 
was specific as no change was observed for HLA-DR or 
tumor necrosis factor-a receptor expression. Northern 
blot hybridization studies confirmed that ICAM-l an-
tisense oligonucleotides selectively and significantly 
inhibited ICAM-l expression. These results suggest 
that such antisense compounds interact with keratino-
cytes differently than other cell types, and provide the 
in vitro basis for clinical trials in which reduction (or 
elimination) ofICAM-l expression by epidermal ker-
atinocytes could be selectively accomplished without 
necessarily influencing dermal cell types such as fibro-
blasts, endothelial cells, or smooth muscle cells. Key 
words: lipofectin, T-cell adhesion, cytokines,fibroblasts. ] In-
vest Dermato1103:569-575, 1994 
creased a thousandfold by using a liposomal preparation containing 
cationic lipid [7]. Cationic Iiposomes also markedly changed the 
subcellula.r distribution of fluorescein-labeled antisense oligonucle-
otides from a punctate cytoplasm pattern in the absence ofliposomes 
to a nuclear localization in the presence of lipids [7]. In this report 
we further characterized ICAM-l antisense oligonucleotides using 
cultured human keratinocytes both in the presence and absence of 
cationic lipid. 
Keratinocytes normally do not express ICAM-l ill vitro or ill vivo 
[8] . However, aberrant keratinocyte ICAM-1 expression has been 
pathophysiologically implicated in retention of T lymphocytes 
within the epidermis in a wide variety of acute and chronic skin 
diseases (reviewed in [9]) . In addition to mediating T-cell binding 
via fJ2 integrins (i.e., lymphocyte function-associated antigen-1 
[LFA-1]), keratinocyte ICAM-l has also been recently recognized 
for playing an important role in the accessory cell function of 
gamma interferon (IFN-y)-treated keratinocytes pulsed with bac-
terial-derived superantigens [10]. Thus, reducing or eliminating 
keratinocyte ICAM-1 expression ill vivo may have significant thera-
peutic benefits with respect to T-cell trafficking and activation in 
cutaneous immune disorders. As a prelude to developing a topical 
formulation for these oligonucleotides ill villo, we further character-
ized the interaction of these molecules with cultured keratinocytes, 
and compared their intracellular localization patterns in the absence 
of cationic lipid with other non-epithelial cell types. 
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Figure 1. Keratinocytes rapidly t~ke up ant~sense oligonucle.otides: CellularIocalization ofFI~C-labeled ISIS 2302 without lipofectin after ~5 min 
(A), 30 min (B), and 240 min (C) , wIth conconuttant presence of hpofectm, 240 mm (D). N ote two different patterns: granular cytoplasmic predommantly 
seen in A and B; homogeneous nuclear reactivity with accentuation of nucleoli (C and D). Bar, 20)1.. 
MATERIALS AND METHODS 
Cell culture Primary keratinocyte cultures were obtained after informed 
consent (and approval of the University of Michigan Human Subjects Com-
mittee) from normal appearing skin of healthy adult volunteers w ithout any 
skin disease, using a Castroviejo keratome. All specimens were obtained 
from the lower back or buttocks region after il~ection of lidocaine withont 
epinephrine to achieve local anesthesia. A typical keratome sample measured 
1.0 X 3.0 X 0.3 cm. A single cell suspension of keratinocytes was prepared 
Table I. Keratinocyte Nuclear Uptake of Antisense and 
Sense Oligonucleotides 
15 min 
30 min 
60 min 
120 min 
240 min 
300 min 
Percent of Keratinocytes with Nuclear Localization of 
5 )1.M FITC-Iabeled ISIS-2302 Antisense or ISIS-8433 
Sense Oligonucleotide" 
Absence of Cationic Lipid Presence of Lipofectin 
ISIS-2302 ISIS-8433 ISIS-2302 
0 8±2 
11 ± 3b 13 ± 3d 29 ± 6' 
14 ± 3 18 ± 4 32± 9 
26±4 58 ± 10 
39 ± 5 43± 5 79 ± 14 
38 ± 5 81 ± 14 
• Values arc expressed as the mean ± SD of three experiments. 
• The extent of antisense oligonucleotide uptake in the absence of cationic lipid was 
significant (p < 0.01) at all time points between 30 min and 300 min. 
, T he enhanced uptake of antisense oligonucleotide in the prescnce of lipofectin was 
significantly greater (p < 0.01) than in the absence of cationic lipid at time points 
between 30 min and 300 min. 
d W hen the sense oligonucleotide was used (ISIS-8433), no significant difference in 
extent of nuclear uptake was seen as compared to IS1S-2302. 
as previously described [11]. Fresh ly isolated epidermal cells were seeded 
into 35-mm plastic petri dishes and grown in the presence of a low-calcium, 
serum-free growth medium designated KGM (C lone tics Corp, San Diego, 
CAl, and used between passage number 2 and 4 being placed into either 
35-mm dishes, 10-cm dishes, or 8-well LabTek chambers (Luk, Flow Labo-
ratories, Naperville, IL) as previously described [11]. Human umbilical vein 
endothelial cells, fibroblasts, and vascular smooth muscle cells (all obtained 
from Clone tics Corp), were grown in the presence of 10% fetal bovine 
serum and relevant additives as previously described [5]. 
Antisense Oligonucleotide Target Sites on Human ICAM-l mRNA 
A series of phosphorothioate oligonucleotides, 18 to 20 bases in length, were 
designed to hybridize to different regions of the human ICAM-l mRNA. 
Four oligonucleotides were identified that significantly reduced ICAM-1 
expression in endothelial cells and the human lung carcinoma cell line A549. 
(See below for sequences from 5'-3' order). ISIS 3067 targets ICAM-l 
mRNA at the 5' end corresponding to the si te in the DNA where transcrip-
tion is initiated as defined by Degitz ct al [12] . ISIS 1570 targets the AUG 
translation initiation codon, whereas ISIS 2302 and ISIS 1939 target se-
quences in the 3'-untranslated region of ICAM-1 mRNA. ISIS 8433 is a 
sense control sequence for ICAM-l , and ISIS 8421 is a four-base mismatch, 
and ISIS 8424 a ten-base mismatch, of ISIS 2302 ICAM-l antisense oligo-
nucleotide. Phosphorothioate antisense oligonucleotides were synthesized 
as previously described [6] . Oligonucleotides were labeled with fluorescein 
on the 5' end using a fluorescein phosphoramidite (Clontech, Palo Alto, CAl 
as the last coupling step. Oligonucleotides were labeled with fluorescein or 
rhodamine on the 3' end as previonsly described [7] . Similar results were 
obtained with oligonucleotides labeled on either the 5' or 3' ends. For ISIS 
compounds, number, sequence, and specificity are as follows: 1570, 
TGGGAGCCATAGCGAGGC, ICAM-l; 1939, CCCCCACCACTTCC-
CCTCTC, ICAM-l; 2302, GCCCAAGCTGGCATCCGTCA, rCAM-1 ; 
3067, TCTGAGTAGCAGAGGAGCTC, rCAM-I; 8433, TGACGG-
ATGCCAGCTTGGGC, ICAM-1 sense control; 8421, GCCCCATC-
GGGCATACGTCA, four-base mismatch of 2302; and 8424, GACG-
CATCGCGCCTACATCG, ten-base mismatch of 2302. 
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Indirect Immunofluorescence Staining and Flow Cytometry For 
cellular localization studies, keratinocytes, fibroblasts, smooth muscle cells, 
and endothelial cells were grown in LabTek chambers and exposed to fluo-
rescein isothiocyanate (FITC)-labeled or rhodamine-labeled ISIS 2302 
prepared as previously described [7]; in the presence and absence oflipofectin 
reagent (hereafter referred to as lipofectin, which is a 1: 1 (w /w) liposone 
formulation of N -[ 1-2(2,3-dioleyloxy)propyl]-N ,N ,N -trimethylammon-
ium chloride and dioleoyl phosphatidylethanolamine, obtained from Gibco, 
Bethesda Research Labs, Bethesda, MD). At the indicated times of incuba-
tion, cells were fixed using 2% freshly prepared para formaldehyde for 20 
rnins at 25°C, and the subcellular localization (cytoplasmic/nuclear) of 
FITC-labeled ISIS 2302 and ISIS 8433 was determined manually by count-
ing 100 consecutive cells using an Olympus BH-2 fluorescent microscope. 
For flow-cytometric analysis, indirect immunofluorescence staining was 
accomplished using a panel of monoclonal antibodies combined with a 
FITC-conjugated goat anti-mouse antibody as previously described [9]. Pri-
mary monoclonal antibodies included anti-ICAM-l (Genzyme Corp, 
Cambridge, MA), anti-HLA-DR (L243; Becton-Dickinson, Mountain 
View, CAl, anti-TNF-a receptor (p60-Genzyme Corp), and Leu 2a (IgG 
isotype control; Becton-Dickinson). Preliminary studies were performed to 
establish optimal staining concentrations for each reagent. For flow cytome-
try. data are expressed as the mean fluorescence intensity from duplicate 
samples. Analysis was done using a FACScan (Becton-Dickinson) equipped 
with Lysis 2 software. 
Northern Blot Hybridization Studies Keratinocytes were grown to 
80% confluence in 75-cm2 flasks and washed three times in serum-free 
medium (Opti-MEM), then treated with 0.5 or 51lM of the indicated 
ICAM-l phosphorothioate antisense oligonucleotides in the presence of 
20 pg/ml lipofectin for 4 h at 37°C. Medium was removed and replaced 
with KGM containing 500 units/ml of IFN-y. Cells were incubated an 
additional 2 h, then total cellular RNA was extracted and probed with either 
human ICAM-l or glyceraldehyde 3-phosphate dehydrogenase (G3PDH) 
eDNA probes labeled by random priming as previously described [6]. The 
level of each transcript was quantitated by Phosphor Image (Sunnyvale, CAl 
analysis of the Northern Blots. 
Statistical Evaluation For all results, a representative experiment is por-
trayed. Similar results were obtained in at least three separate experiments 
except for the data described in Fig 8, which was only confirmed by one 
additional experiment. Differences in the mean values obtained from the 
ELISA were evaluated for statistical significance using the Student t test; p 
values less than 0.01 were considered significant. 
RESULTS 
Keratinocyte Subcellular Distribution of FITC-Labeled 
ISIS-2302 in the Presence and Absence ofLipofectin In the 
absence of cationic lipid, within the first 15 min of adding 5 J,lM 
FlTC-labeled ISIS-2302, there was granular cytoplasmic fluores-
cence observed in greater than 50% of the keratinocytes (Fig 1a). 
By 30 min, occasional keratinocytes (10%) had nuclear fluorescence 
staining patterns (Fig 1b). By 240 min, many keratinocytes (39%) 
had prominent accumulation in their nuclei, with accentuation of 
the nucleolus (Fig 1c). The temporal sequence of initial cytoplas-
mic localization followed by nuclear uptake is similar to our 
previous experience using endothelial cell mono layers in the pres-
ence of cationic liposomes [7]. The relative number ofkeratinocytes 
with nuclear fluorescence at each sampled time point is summarized 
in Table I. It should be noted that localization of the ISIS-2302 in 
specific cellular compartments of keratinocytes was not due to the 
fluorescence dye, as the same oligonucleotide labeled with rhoda-
mine gave similar results (data not shown). Also, the observed fluo-
rescence was not due to free fluorescein, as keratinocytes incubated 
with 1 J,lM fluorescein did not produce any uptake. The specific 
uptake patterns were not a fixation artefact, because examination of 
monolayers prior to fixation revealed similar patterns in unfixed 
keratinocytes. Also, examination of keratinocytes for total cellular 
uptake of FITC-labeled ISIS 2302 without lipofectin as quantified 
independently by flow cytometry (Fig 2) confirmed the results as 
presented in Fig 1 and Table I. Importantly, the direct uptake of 
1515-2302 into nuclei in the absence of lipofectin by keratinocytes 
appeared to be cell-type specific, as repeated attempts to observe 
similar nuclear immunofluorescence were unsuccessful using cul-
tured endothelial cells, fibroblasts, or smooth muscle cells (Fig 
3a,b,c) even after 30 h of co-incubation. As can be seen, with these 
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Figure 2. Flow-cytometry confirms rapid uptake of antisense oligo-
nucleotides by keratinocytes. Cells were incubated with 5 tIM fluores-
cein-labeled ISIS 2302 for the indicated periods of times. Cells were thor-
oughly washed and fluorescence associated with the cells was determined by 
flow cytometry. Note the rapid total cellular uptake by kerarinocytes that is 
present at 30 min and persists up to 21 h. 
non-keratinocyte cell types, only granular/punctate cytoplasmic re-
activity of FITC-labeled ISIS 2302 was observed. 
To determine if the enhanced nuclear uptake of ISIS 2302 by 
keratinocytes was due to significantly enhanced total cellular uptake 
compared to the other cell types of interest, a direct comparative 
study was performed. The total cellular uptake of ISIS 2302 was 
approximately equivalent among all cells studied throughout the 
initial 6 h, although by 21 h, differences were observed with kerati-
nocytes and fibroblasts having the highest levels of mean fluores-
cence staining, followed by smooth muscle cells and endothelial 
cells (Fig 4). However, it appears that the total lack of nuclear 
uptake of the antisense compound in the non-keratinocytes (partic-
ularly fibroblasts) could not be explained by the lack of cytoplasmic 
entry, because considerable total cellular uptake was observed for all 
cell types during the 21 h of incubation with FITC-labeled ISIS 
2302. 
When the cationic lipid-lipofectin was combined with FITC-la-
beled ISIS 2302, there was significantly more rapid and widespread 
nuclear uptake in keratinocytes. Table I demonstrates that as early 
as 15 min 8% of the keratinocytes has nuclear staining, which 
quickly increased to 29% of the cells by 30 min. Greater than 75% 
of the keratinocytes expressed strong fluorescence reactivity in the 
nuclei with accentuation of the nucleolus by 240 min in the co-pre-
sence of lipofectin (Fig 1d). 
Inhibition of Keratinocyte Cell Surface Expression of 
ICAM-l by ISIS-2302 Based on uptake studies, keratinocytes 
were exposed to ISIS 2302 (with/without lipofectin) for 4-6 h 
prior to addition of IFN-y. After 48 h fo llowing IFN-y exposure, 
keratinocyte cell surface ICAM-1 was assessed by indirect immuno-
fluorescence staining and fluorescence-activated cell sorter analysis. 
The 48-h timepoint of co-incubation was chosen because another 
IFN-y-inducible gene product-class II major histocompatibility 
complex molecule- HLA-DR, is maximally expressed at this point 
[11]. Also, we examined a constitutively expressed cell surface 
molecule-the TNF-a receptor as a control for specificity. 
Cultured keratinocytes do not express detectable ICAM-1 by flu-
orescence-activated cell sorter analysis (mean channel fluorescence 
value, (x = 7) prior to adding IFN-y (Fig 5, top). When IFN-y (10 
U /ml) is added, keratinocytes are induced to express ICAM-1 (x = 
87), which is reduced to a X of 43 when these same cells are pre-in-
cubated with 5 J,lM ISIS 2302 plus lipofectin (5 J,lg/ml) (Fig 5, top) . 
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Figure 3. Non-epithelial cell types fail to display nuclear uptake of antisense oligonucleotides. Cellular localization of FlTC-labeled ISIS 2302 
without lipofectin (4 h) reveals only granular/punctate cytoplasmic reactivity in human umbilical vein endothelial cells (A) , fibroblasts (B), and smooth 
muscle cells (C) . Note the complete absence of any nuclear uptake. Bar, 20 J1.. 
Cultured keratinocytes also do not constitutively express HLA-DR 
(x = 7), but after exposure to IFN-y (10 U /ml), HLA-DR expres-
sion (x = 61) is induced (Fig 5, middle). In contrast to the reduction 
ofICAM-1 expression caused by pre-incubation with ISIS 2302, no 
inhibition is seen for the induction of HLA-DR (x = 71). With 
respect to ISIS 2302, when lipofectin is absent there is still a reduc-
tion in the ability ofIFN-y to induce ICAM-1 from axvalue of87 to 
59 (Fig 5, bottom). Figure 6 summarizes representative results for 
the inhibitory effects of ISIS-2302 on keratinocyte ICAM-1 using 
four different concentrations ofIFN-y in the absence and presence 
of lipofectin. For all experiments, the relative percentage of inhibi-
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Figure 4. Quantitation by flow cytometry of total FITC-Iabeled 
ISIS 2302 uptake by keratinocytes, fibroblasts, smooth muscle cells, 
and endothelial cells. Primary human dermal fibroblasts (open circles), 
human keratinocytes (closed triallgles), human aortic smooth muscle cells 
(open squares), and human umbilical vein endothelial cells (closed djamonds) 
were incubated with 5 J1.M fluorescein-labeled ISIS 2302 for the indicated 
period of time. Cells were washed and oligonucleotide associated with the 
cells was determined by flow cytometry. Note that up to 6 h there was 
approximately equivalent increases in total cellular uptake. and at 21 h 
fibroblasts and keratinocytes contained more antisense compound than 
smooth muscle cells and endothelial cells. 
tion was determined by comparing the mean channel fluorescence 
values of the uniformly staining keratinocyte population that had 
been exposed to IFN-y with or without pre-treatment with ISIS 
2302 (plus/ minus lipofectin) . When the TNF-a cell surface recep-
tor was measured, there was no change in the X of 73, either by 
exposing the keratinocytes to IFN-y and/or ISIS 2302. A summary 
of the ability of ISIS 2302 to reduce the fluorescence intensity of 
IFN-y- induced ICAM-1 by 50% without changing the fluores-
cence intensity for either HLA-DR or TNF-a receptor is presented 
in Table II. 
Inhibition ofKeratinocyte ICAM-l mRNA By Antisense Ol-
igonucleotides Using Northern Blot Analysis Using North-
ern blot analysis, the relative order of potency was measured for the 
different ICAM-1 antisense oligonucleotides (Fig 7). Quantitation 
of relative band intensities revealed that ISIS 2302 reduced IFN-y-
induced ICAM-l expression by 91.7%, ISIS 3067 by 76.5%, ISIS 
1939 by 59.4%, and ISIS 1570 by 39.5%; when samples were nor-
malized for glyceraldehyde 3-phosphate dehydrogenase (G3PDH) 
expression (Fig 7) . None of the oligonucleotides significantly 
changed the level of G3PDH transcript, a constitutively expressed 
housekeeping gene product. 
Figure 8 reveals that the reduction in ICAM-1 mRNA by ISIS 
2302 was dependent on the specific sequence chosen for ICAM-l, 
because using a sense (rather than antisense sequence; ISIS 8433, 
lane D), or using either a four-base or 10-base mismatch ofISIS 2302 
(designated ISIS 8421 and 8424 in lanes E and F, respectively), had 
no inhibitory effect on IFN-y-induced ICAM-1 mRNA expres-
sion. It should be noted that when using FITC-labeled ISIS 8433, 
the same extent of total cellular uptake and nuclear localization was 
observed in keratinocytes as portrayed for ISIS 2302 in Figs 1 and 2 
and Table I. Thus, the lack of inhibition ofICAM-l expression by 
the sense oligonucleotide was not due to its subcellular localization 
distribution profile. 
DISCUSSION 
The most important new observation in this report is that keratino-
cytes can rapidly take up antisense oligonucleotides within their 
nuclei, and function as potent and specific inhibitors of ICAM-l 
expression, without requiring the co-presence of a cationic lipid. 
We have previously demonstrated that phosphorothioate oligonu-
cleotides were effective inhibitors ofICAM-l expression in human 
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Figure S. Flow cytometric analysis ofICAM-l and HLA-DR expres-
sion in cultured keratinocytes. Top: ICAM-l expression without IFN-y 
(shaded wrve, left side), and after IFN-y exposure to 10 Ulml, 48 h (shaded 
curve, right side). Fluorescence intensity is reduced when keratinocytes are 
pre-treated for 4 h with ISIS 2302 (5 J.lM) and lipofectin (5 J.lg/ml) prior to 
adding IFN-y (open curve) . Middle: HLA-DR expression without IFN-y 
(shaded curve, left side), and after IFN-y exposure (shaded curve, right side). No 
change in fluorescence intensity when cells are pre-treated with ISIS 2302 
plus lipofectin (open curve). Bottom: ICAM-l expression without IFN-y 
(shaded curve, left side), and after exposure to IFN-y (shaded curve, right side) . 
Fluorescence intensity is reduced when cells are pre-treated with ISIS-2302 
in the absence of lipofectin prior to adding IFN-y (opell curve). 
umbilical vein endothelial cells and a human lung carcinoma cell 
line when delivered in the presence of cationic liposomes [1,6] . The 
effectiveness of the oligonucleotides was dependent, in part, on 
what region of the ICAM-l mRNA they were designed to hybri-
dize to. The most effective oligonucleotides hybridized to regions 
in the 3'-untranslated region of ICAM-1 mRNA [1,6]. We have 
extended those studies to multi-passaged epidermal keratinocytes, 
demonstrating inhibition of ICAM-1 expression by ICAM-1 anti-
sense oligonucleotides. Using keratinocytes, ICAM-l antisense oli-
gonucleotides inhibited ICAM-1 expression even in the absence of 
cationic liposomes at concentrations between 1 and 5 ,uM. In human 
ICAM-l ANTISENSE OLIGONUCLEOTIDES AND KERATINOCYTES 573 
60 
50 
~ e..- 40 c 
0 
= :0 
E 30 £ 
~ 
~ 
<t: 20 ~ 
10 
0 
+ 
10 
. + 
50 
l'Sl 
II 
minus Lipofeclin 
plus Lipofectin 
+ 
500 
+ 
1000 
IFN-y (U/ml) plus 2302 (5~) +1· Lipofeclin 
Figure 6. Summary of ability of ISIS 2302 (S J.lM) used with four 
different concentrations (ranging from 10-1000 U Iml) ofIFN-y to 
inhibit ICAM-l expression as determined by flow cytometry. Note 
that with each IFN-y concentration, addition oflipofectin (5 J.lg/ml) signif-
icantly enhanced (p < 0.01) the ICAM-1 inhibitory effect of the antisense 
oligonucleotide. The SEM is less than 20% for all values. 
umbilical vein endothelial cells, a twentyfold higher concentration 
of antisense oligonucleotide failed to inhibit ICAM-1 expression in 
the absence of cationic liposomes [6]. 
The mechanism by which oligonucleotides pass through the 
plasma membrane, gaining access to cellular RNA, is complex and 
poorly understood. Several reports have characterized uptake of 
phosphorothioate oligonucleotides into a variety of cell type [7,13-
19]. Phosphorothioate oligonucleotides appear to concentrate 
within cells in a time- and temperature-dependent manner, sug-
gesting that they do not passively cross the plasma membrane. Sev-
eral reports suggest that charged oligonucleotides bind proteins on 
the cell surface, and are internalized by an endocytotic process 
[15,16,20]. Once present in the cytoplasm, oligonucleotides rapidly 
migrate to the nucleus. It is possible that the use of phosphorothio-
ate oligonucleotides via their nuclease resistance may lead to in-
creased toxicity from prolonged nonspecific binding, which will 
require further study in an in vivo clinical setting. 
Primary epidermal keratinocytes appear to readily take up phos-
phorothioate oligonucleotides in the absence of cationic lipids (Figs 
1 and 2). When compared to fibroblasts, smooth muscle, and endo-
thelial cells, keratinocytes were found to accumulate almost twice as 
much total cellular oligonucleotide (ISIS 2302) as endothelial cells, 
Table II. Flow Cytometric Analysis of Untreated and 
IFN-y- Treated Keratinocytes 
Untreated cells 
IFN-y (10 U/ml, 48 h) 
Pre-treated! 
Mean Channel Flourescence Values 
Determined by FACS Analysis for 
Keratinocytes' 
TNF-a IgG 
ICAM-1 HLA-DR Receptor Control 
7 7 35 6 
87 61 38 8 
43 71 37 8 
• Values were derived from a single representative experiment. Similar results were 
observed in two additional experiments. 
I Pre-treated with ISIS 2302 (5 I'M) plus lipofectin (5 pg/ ml) for 4 h prior to adding 
IFN-y (to U/m.l). 
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and were slightly less efficient than fibroblasts (Figs 3 and 4). 
Interestingly, keratinocytes were distinguished from these other 
cell types by their nuclear localization without lipofectin (Figs 
1-4). Thus, in keratinocytes the internalized oligonucleotides 
escaped the cytoplasmic vesicles and accumulated in the nucleus. 
Specific inhibition of ICAM-1 expression correlated with appear-
ance of oligonucleotide in the nucleus in the absence of cationic 
lipids. The mechanism by which oligonucleotides escape or bypass 
the endocytotic pathway in keratinocytes is not known. Because 
fibroblasts accumulate slightly more total cellular oligonucleotide 
than keratinocytes, the data cannot be explained by the keratino-
cytes simply accumulating more oligonucleotide within the cell. 
Nuclear localization of oligonucleotide was also observed with the 
transformed A431 epidermal carcinoma cell line (data not shown). 
Therefore, there may be unique characteristics with epidermal cells 
that allow oligonucleotides to escape or bypass the endocytotic 
pathway. Elucidation of this pathway in keratinocytes is under ac-
tive investigation. 
Our results demonstrate that ISIS 2302 can biologically influence 
keratinocytes in the absence of lipofectin, but the overall extent of 
nuclear uptake and ability to inhibit IFN-y induced ICAM-1 ex-
pression was clearly enhanced by the addition oflipofectin. Nuclear 
localization ofFITC-labeled ISIS 2302 was approximately doubled 
for a maximum of 38-39% up to 79 -81% by adding lipofectin 
(Table I), and the flow-cytometric analysis for cell surface ICAM-1 
protein levels was also clearly influenced by adding lipofectin with 
the antisense compound (Figs 5 and 6). Additional verification of 
the biologic effects of the antisense compound was provided by 
Northern blot hybridization studies (Fig 7). The specificity of the 
inhibitory effects of the oligonucleotides was confirmed by the lack 
of influence of two constitutively expressed gene products (TNF-a 
receptor and G 3PD mRN A), as well as the lack of influence on the 
IFN-y inducible gene product: HLA-DR. Furthermore, only anti-
sense oligonucleotides of appropriate sequences targeted at ICAM-1 
chromosomal gene were effective in reducing ICAM-1 mRNA ex-
pression (Fig 8). The failure of the sense oligonucleotide ISIS 8433 
to inhibit ICAM-1 expression was not a result of its inability to enter 
the nucleus ofkeratinocytes, as even without lipofectin the kinetics 
and extent of nuclear uptake by FITC-labeled ISIS 8433 was identi-
cal to ISIS 2302. 
The immunologic ramifications of these results extend beyond 
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Figure 7. Effects of various antisense oligonucleotides on keratino-
eyte ICAM-l mRNA expression before/after exposure to IFN-y 
(500 U/ml; 2 h) by Northern blot analysis. All antisense oligonucleo-
tides were used at 5 JlM in the co-presence oflipofectin (5 Jlg/ml). Note that 
compared to IFN-y-treated keratinocyte cultures without antisense oligo-
nucleotides, the addition of ISIS compounds 2302, 3067,1939, and 1570 
reduced ICAM-1 mRNA signals, but not the G3PDH mRNA signals. ISIS 
2302 was the most potent compound at reducing IFN-y-induced ICAM-1. 
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Figure 8. Ability ofISIS 2302 in reducing IFN-y-induced ICAM-l 
mRNA expression is not shared by other oligonucleotide sequences. 
All oligonucleotides were used at 5 Jlm with lipofectin as described in Fig 7. 
A: keratinocytes without IFN-y. B: keratinocytes exposed to IFN-y. c: 
IFN-y-exposed keratinocytes pre-treated with ISIS 2302 (ICAM-1 anti-
sense oligonucleotide). D: IFN-y-exposed keratinocytes pre-treated with 
ISIS 8433 (ICAM-1 sense oligonucleotide). E: IFN-y-exposed keratino-
cytes pre-treated with ISIS 8421 (four-base mismatch of ISIS 2302). F: 
IFN-y-exposed keratinocytes pretreated with ISIS 8424 (ten-base mis-
match of ISIS 2302). Note that only ISIS 2302 could significantly reduce 
ICAM-1 mRNA expression. 
the interesting cell biology issues addressed above regarding the 
mechanism by which these antisense oligonucleotides can enter the 
nuclei ofkeratinocyte without requiring the co-presence of cationic 
lipids. By virtue of significantly reducing keratinocyte ICAM-1 
expression on the cell surface, these antisense oligonucleotides may 
be capable of interrupting critically important keratinocyte:T -cell 
interactions in a wide variety of skin diseases. Indeed, a growing 
body of evidence points to epidermal keratinocyte as key immuno-
cytes of the integument, and these immunologic reactions are me-
diated by the cell surface expression of ICAM-l [21]. Only clinical 
trials using topically administered antisense oligonucleotides will 
provide definitive evidence to support a key role for keratinocyte 
ICAM-1 expression in T -cell- mediated dermatoses. By omitting 
cationic lipids, it may be possible to achieve not only molecular 
specificity (i. e., ICAM-1 and not HLA-DR), but also cell-type spec-
ificity (keratinocytes and not dermal cell types) for targeting this 
emerging new class of therapeutic agents at various skin disorders. 
This work was sl4pported ill part by NIH grants AR40065, 01823, and 40488 
(BJN), and a grant from ISIS Pharmaceuticals, Illc. 
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